Blog
Article from Pearl IRB staff featured in SCRS InSite magazine
Check out this article (login registration is required) entitled "What could proposed changes to the Common Rule mean to sites, sponsors and IRBs" published in the Q2 2013 edition of the Society for Clinical Research Sites' online journal, InSite. This article was a...
Job opening – Regulatory publication coordinator
We are looking for a new talent to join the Pearl team. Effective immediately, Pearl Pathways in Indianapolis, Indiana has a new position open for a Regulatory Publication Coordinator. Please see the job description online here. Experience with eCTD for an NDA or...
Pathways’ President & CEO Diana Caldwell to be panelist in upcoming Site Solutions Summit
The 2013 Site Solutions Summit features Pearl Pathways’ own Diana Caldwell. She will be involved in the roundtable discussions as a panelist and moderator for topics such as: Investigator Insider: What your site needs to know about your next potential investigator;...
EFPIA announces position against EMA draft policy
Pharmalive.com’s Ed Silverman reports that in another attempt to stop the European Medicines Agency (EMA) from continuing with their new policy for trial data disclosure, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has openly...
Tufts releases report on causes of drug development failures
On September 10, 2013, the Tufts Center for the Study of Drug Development released a report concerning the leading causes of failures in drug development. Based on a study of products that entered clinical development from 2000 through 2009, the study found that Phase...